Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C28H27N3O4 |
| Molecular Weight | 469.5317 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N([C@H]2CCC(=O)NC2=O)C3=CC=C(CC4=CC=C(CN5CCOCC5)C=C4)C6=C3C1=CC=C6
InChI
InChIKey=MUKCJOOKCZSQNW-DEOSSOPVSA-N
InChI=1S/C28H27N3O4/c32-25-11-10-24(27(33)29-25)31-23-9-8-20(21-2-1-3-22(26(21)23)28(31)34)16-18-4-6-19(7-5-18)17-30-12-14-35-15-13-30/h1-9,24H,10-17H2,(H,29,32,33)/t24-/m0/s1
| Molecular Formula | C28H27N3O4 |
| Molecular Weight | 469.5317 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:55:01 GMT 2025
by
admin
on
Wed Apr 02 08:55:01 GMT 2025
|
| Record UNII |
D86MF5H9WJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
831921
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000040689
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
C179502
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
2504235-67-8
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
12505
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
MN-120
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
D86MF5H9WJ
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY | |||
|
155207651
Created by
admin on Wed Apr 02 08:55:01 GMT 2025 , Edited by admin on Wed Apr 02 08:55:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->DEGRADER |
IN-VITRO
|
||
|
TARGET->DEGRADER |
IN-VITRO
|
||
|
TARGET->LIGAND |
IN-VITRO
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
The high CRBN binding affinity of CFT7455 enables rapid, deep and durable degradation of IKZF1 and IKZF3 resulting in potent growth inhibitory activity in multiple myeloma cell lines and multiple types of non-Hodgkin’s lymphoma cell lines in vitro
|